Skip to main content

Advertisement

Log in

The value of chest and skeletal staging studies in conventional chondrosarcoma

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objective

To determine the value of chest and skeletal staging in patients presenting with conventional chondrosarcoma (CS).

Materials and methods

Retrospective review of patients with CS diagnosed between January 2007 and December 2019. Data collected included age, sex, skeletal location and results of chest CT and whole-body bone scintigraphy (WB-BSc) obtained at initial diagnosis. The histological tumour grade based on surgical resection or needle biopsy was classified as low-grade (LGCT), high-grade (HGCT) and dedifferentiated (DD-CS). Findings of chest CT and WB-BSc were correlated with tumour grade.

Results

Four hundred twenty patients were included (234 males and 186 females with mean age 54.5 years, range 9–91 years). The major long bones were involved in 205 cases, the flat bones in 166 cases, the mobile spine in 14 cases and the small bones of the hands and feet in 35 cases. Three hundred fifty tumours were central in location, 39 peripheral and 31 on the surface of the bone. There were 151 LGCTs, 196 HGCTs and 73 DD-CSs. Of patients with LGCT, 41.7% underwent chest CT and 25.2% WB-BSc. Of patients with HGCT, 95.4% underwent chest CT and 76.5% WB-BSc. Of patients with DD-CS, 98.6% underwent chest CT and 86.3% WB-BSc. Metastases were diagnosed in 2 (3.3%) chest CT studies and 0 WB-BSc in LGCT, in 8 (4.3%) chest CT studies and 0 WB-BSc in HGCT and in 21 (30%) chest CT studies and 6 (21%) WB-BSc in DD-CS.

Discussion

Staging chest CT and WB-BSc is of little or no value except in DD-CS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Strauss SJ, Whelan JS. Current questions in bone sarcomas. Curr Opin Oncol. 2018;30(4):252–9. https://doi.org/10.1097/CCO.0000000000000456.

    Article  PubMed  Google Scholar 

  2. Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188–93. https://doi.org/10.1200/JCO.2017.75.1743 Epub 2017 Dec 8.

    Article  CAS  PubMed  Google Scholar 

  3. Gerrand C, Athanasou N, Brennan B, Grimer R, Judson I, Morland B, et al. UK guidelines for the management of bone sarcomas. Clin Sarcoma Res BioMed Central. 2016;6(1):7.

    Article  Google Scholar 

  4. Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv79–95. https://doi.org/10.1093/annonc/mdy310 Epub 2020 Jan 7.

    Article  CAS  PubMed  Google Scholar 

  5. Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am. 2013;95(13):e89. https://doi.org/10.2106/JBJS.L.01189.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ramkumar DB, Ramkumar N, Miller BJ, Henderson ER. Risk factors for detectable metastatic disease at presentation in Ewing sarcoma - an analysis of the SEER registry. Cancer Epidemiol. 2018;57:134–9. https://doi.org/10.1016/j.canep.2018.10.013 Epub 2018 Nov 6.

    Article  PubMed  Google Scholar 

  7. Xie L, Huang W, Wang H, Zheng C, Jiang J. Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study. J Orthop Surg Res. 2020;15(1):32. https://doi.org/10.1186/s13018-020-1571-5.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rozeman LB, Cleton-Jansen AM, Hogendoorn PC. Pathology of primary malignant bone and cartilage tumours. Int Orthop. 2006;30(6):437–44 Epub 2006 Aug 30.

    Article  CAS  Google Scholar 

  9. Fromm J, Klein A, Baur-Melnyk A, et al. Survival and prognostic factors in conventional central chondrosarcoma. BMC Cancer. 2018;18(1):849. https://doi.org/10.1186/s12885-018-4741-7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Grimer RJ, Gosheger G, Taminiau A, et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer. 2007;43(14):2060–5 Epub 2007 Aug 27.

    Article  Google Scholar 

  11. Miao R, Choy E, Raskin KA, et al. Prognostic factors in dedifferentiated chondrosarcoma: a retrospective analysis of a large series treated at a single institution. Sarcoma. 2019;2019:9069272. https://doi.org/10.1155/2019/9069272 eCollection 2019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. McLoughlin E, Davies AM, Iqbal A, James SL, Botchu R. The diagnostic significance of pulmonary nodules on CT thorax in chondrosarcoma of bone. Clin Radiol. 2020;75(5):395.e7–395.e16. https://doi.org/10.1016/j.crad.2019.11.017 Epub 2019 Dec 31.

    Article  CAS  Google Scholar 

  13. Douis H, James SL, Grimer RJ, Davies MA. Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone? Skelet Radiol. 2012;41(4):429–36. https://doi.org/10.1007/s00256-011-1252-x. Epub 2011 Sep 3.

    Article  Google Scholar 

  14. Gulia A, Puri A, Byregowda S. Staging investigations in chondrosarcoma: is evaluation for skeletal metastases justified? Analysis from an epidemiological study at a tertiary cancer care center and review of literature. South Asian J Cancer. 2016;5:3–4.

    Article  Google Scholar 

  15. Caparica R, Mak MP, Rocha CH, et al. Pulmonary nodules in patients with non-pulmonary cancer: not always metastases. J Glob Oncol. 2016;2(3):138–44.

    Article  Google Scholar 

  16. Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics. 2003;23(5):1245–78.

    Article  Google Scholar 

  17. Littrell LA, Wenger DE, Wold LE, et al. Radiographic, CT, and MR imaging features of dedifferentiated chondrosarcomas: a retrospective review of 174 de novo cases. Radiographics. 2004;24(5):1397–409.

    Article  Google Scholar 

  18. Douis H, Saifuddin A. The imaging of cartilaginous bone tumours. II Chondrosarcoma. Skelet Radiol. 2013;42(5):611–26. https://doi.org/10.1007/s00256-012-1521-3 Epub 2012 Oct 4.

    Article  CAS  Google Scholar 

  19. Deloin X, Dumaine V, Biau D, et al. Pelvic chondrosarcomas: surgical treatment options. Orthop Traumatol Surg Res. 2009;95(6):393–401. https://doi.org/10.1016/j.otsr.2009.05.004 Epub 2009 Oct 3.

    Article  CAS  PubMed  Google Scholar 

  20. Stevenson JD, Laitinen MK, Parry MC, Sumathi V, Grimer RJ, Jeys LM. The role of surgical margins in chondrosarcoma. Eur J Surg Oncol. 2018;44(9):1412–8. https://doi.org/10.1016/j.ejso.2018.05.033 Epub 2018 Jun 8.

    Article  PubMed  Google Scholar 

  21. Dierselhuis EF, Goulding KA, Stevens M, Jutte PC. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones. Cochrane Database Syst Rev. 2019;3:CD010778. https://doi.org/10.1002/14651858.CD010778.pub2.

    Article  PubMed  Google Scholar 

  22. Fromm J, Klein A, Baur-Melnyk A, et al. Survival and prognostic factors in conventional G1 chondrosarcoma. World J Surg Oncol. 2019;17(1):155. https://doi.org/10.1186/s12957-019-1695-4.

    Article  PubMed  PubMed Central  Google Scholar 

  23. van Praag Veroniek VM, Rueten-Budde AJ, Ho V, et al. Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas. Surg Oncol. 2018;27(3):402–8. https://doi.org/10.1016/j.suronc.2018.05.009 Epub 2018 May 6.

    Article  PubMed  Google Scholar 

  24. Kalus S, Saifuddin A. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review. Eur Radiol. 2019;29(10):5700–8. https://doi.org/10.1007/s00330-019-06132-9 Epub 2019 Mar 26.

    Article  PubMed  Google Scholar 

  25. Saifuddin A, Sharif B, Oliveira I, Kalus S, Barnett J, Pressney I. The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas. Skelet Radiol. 2020;49(6):945–54. https://doi.org/10.1007/s00256-019-03369-9 Epub 2020 Jan 9.

    Article  Google Scholar 

  26. Jurik AG, Jørgensen PH, Mortensen MM. Whole-body MRI in assessing malignant transformation in multiple hereditary exostoses and enchondromatosis: audit results and literature review. Skelet Radiol. 2020;49(1):115–24. https://doi.org/10.1007/s00256-019-03268-z Epub 2019 Jul 5.

    Article  Google Scholar 

  27. Hanamiya M, Aoki T, Yamashita Y, Kawanami S, Korogi Y. Frequency and significance of pulmonary nodules on thin-section CT in patients with extrapulmonary malignant neoplasms. Eur J Radiol. 2012;81(1):152–7. https://doi.org/10.1016/j.ejrad.2010.08.013 Epub 2010 Sep 15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ines Oliveira.

Ethics declarations

The study was approved by the local Research and Innovation Centre of the Institute of Orthopaedics under the Integrated Research Application System number 262826, with no requirement for informed patient consent.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oliveira, I., Singla, N., Chavda, A. et al. The value of chest and skeletal staging studies in conventional chondrosarcoma. Skeletal Radiol 50, 125–135 (2021). https://doi.org/10.1007/s00256-020-03539-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-020-03539-0

Keywords

Navigation